Mainz Biomed N.V Ratios (2020-2025) | MYNZ

Ratios Dec2020 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Jun2024 Dec2024 Jun2025
Profitability
Gross Margin 46.17%58.04%19.23%18.78%55.55%59.77%47.99%62.74%
EBT Margin -5,631.92%-4,983.27%-5,781.76%-4,236.66%-2,623.28%-3,314.68%-3,467.71%-2,413.53%
EBIT Margin -5,599.92%-4,989.88%-5,657.13%-4,340.30%-2,593.94%-3,183.87%-3,104.90%-3,068.71%
EBITDA Margin 5,595.68%4,950.09%5,715.54%-4,340.30%2,647.49%3,350.84%3,202.69%2,802.51%
Operating Margin -5,599.92%-4,989.88%-5,657.13%-4,340.30%-2,593.94%-3,183.87%-3,104.90%-3,068.71%
Net Margin -5,631.92%-4,983.27%-5,781.76%-4,236.66%-2,623.28%-3,314.68%-3,467.71%-2,413.53%
FCF Margin -2,667.18%-2,529.60%-3,315.54%-3,111.77%-1,902.59%-2,006.51%-3,574.11%-3,208.71%
Efficiency
Inventory Average 0.04M-0.15M
Assets Average 5.36M19.89M19.42M18.61M16.66M11.93M10.85M11.52M
Equity Average 1.81M11.89M7.43M4.31M3.35M-0.44M0.95M4.28M
Invested Capital -2.68M6.44M-0.02M23.80M-0.09M14.17M9.70M5.20M3.46M8.11M-4.25M8.21M2.32M
Asset Utilization Ratio 0.030.040.050.050.762.042.75
Leverage & Solvency
Interest Coverage Ratio -273.07-346.11-286.76-46.04-166.33-120.42-200.44-16.92
Debt to Equity -0.010.210.000.070.000.190.011.50-0.010.17
Debt Ratio 0.040.130.000.050.000.050.000.320.000.08
Equity Ratio -4.070.630.860.700.500.270.190.21-0.490.460.26
Times Interest Earned -273.07-346.11-286.76-46.04-166.33-120.42-200.44-16.92
Valuation
Enterprise Value -0.12M112.94M141.32M59.03M77.76M85.69M69.15M42.62M-7.52M12.36M1.27M-2.33M1.15M
Market Capitalization 121.67M171.32M111.09M99.86M102.83M90.95M70.87M19.26M19.43M8.49M2.76M3.27M
Return Ratios
Return on Sales -49.80%-40.16%-36.24%-33.53%-29.36%
Return on Capital Employed -2.07%-3.25%-3.87%-3.59%
Return on Assets -1.37%-1.47%-1.57%-1.58%
Return on Equity -2.30%-3.85%-6.79%-7.85%